Anvisa approves new indication for HPV vaccine to prevent oropharyngeal, head, and neck cancers
Brazil's health regulatory agency Anvisa has approved a new indication for the HPV vaccine Gardasil 9 to prevent oropharyngeal, head, and neck cancers in individuals aged 9 to 45.
Rwanda: Rwanda to Introduce Vaccine Against Six Cancers
Rwanda plans to introduce Gardasil 9, a new HPV vaccine, to enhance cancer protection and aims to eliminate cervical cancer by 2027, potentially becoming the first African nation to include it in its national immunization program.